X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (855) 855
Publication (186) 186
Book / eBook (9) 9
Patent (9) 9
Book Review (8) 8
Book Chapter (5) 5
Conference Proceeding (4) 4
Newspaper Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (333) 333
index medicus (262) 262
female (209) 209
male (206) 206
middle aged (202) 202
hematology (193) 193
aged (174) 174
adult (158) 158
oncology (148) 148
life sciences (136) 136
cancer (116) 116
rituximab (110) 110
treatment outcome (96) 96
prognosis (91) 91
chemotherapy (89) 89
[ sdv.can ] life sciences [q-bio]/cancer (88) 88
lymphomas (88) 88
aged, 80 and over (84) 84
lymphoma (83) 83
antineoplastic combined chemotherapy protocols - therapeutic use (75) 75
non-hodgkins-lymphoma (72) 72
survival (63) 63
[sdv.can]life sciences [q-bio]/cancer (62) 62
therapy (57) 57
disease-free survival (55) 55
adolescent (54) 54
antineoplastic agents - therapeutic use (52) 52
b-cell lymphoma (51) 51
hemic and lymphatic diseases (50) 50
abridged index medicus (49) 49
patients (49) 49
expression (48) 48
follicular lymphoma (46) 46
france (46) 46
lymphoma, follicular - drug therapy (46) 46
survival analysis (45) 45
young adult (44) 44
analysis (43) 43
retrospective studies (39) 39
cyclophosphamide (38) 38
leukemia (37) 37
prospective studies (37) 37
immunology (35) 35
lymphoma, large b-cell, diffuse - drug therapy (33) 33
elderly-patients (32) 32
follow-up studies (31) 31
risk factors (31) 31
cyclophosphamide - administration & dosage (30) 30
lymphoma, follicular - pathology (30) 30
recurrence (30) 30
antibodies, monoclonal, murine-derived (28) 28
doxorubicin - administration & dosage (28) 28
risk (28) 28
trial (28) 28
antibodies, monoclonal, murine-derived - therapeutic use (27) 27
antineoplastic combined chemotherapy protocols - administration & dosage (27) 27
chronic lymphocytic-leukemia (27) 27
disease (27) 27
human health and pathology (27) 27
medicine, general & internal (27) 27
transplantation (27) 27
vincristine (27) 27
care and treatment (26) 26
doxorubicin (26) 26
kaplan-meier estimate (26) 26
neoplasm staging (26) 26
remission induction (26) 26
time factors (26) 26
disease progression (25) 25
research (25) 25
vincristine - administration & dosage (25) 25
antineoplastic combined chemotherapy protocols - adverse effects (24) 24
diagnosis (24) 24
proportional hazards models (24) 24
survival rate (24) 24
hematology, oncology and palliative medicine (23) 23
immune system diseases (23) 23
prednisone - administration & dosage (23) 23
[ sdv ] life sciences [q-bio] (22) 22
drug therapy (22) 22
lymphoma, large b-cell, diffuse - pathology (22) 22
mutation (22) 22
combined modality therapy (21) 21
cyclophosphamide - therapeutic use (21) 21
pathology (21) 21
[sdv]life sciences [q-bio] (20) 20
anti-cd20 monoclonal-antibody (20) 20
antineoplastic agents - administration & dosage (20) 20
clinical trials (20) 20
doxorubicin - therapeutic use (20) 20
lymphoma, b-cell - genetics (20) 20
lymphoma, large b-cell, diffuse - mortality (20) 20
toxicity (20) 20
immunophenotyping (19) 19
lymphocytes b (19) 19
lymphoma, b-cell - pathology (19) 19
lymphoma, large b-cell, diffuse - genetics (19) 19
medical research (19) 19
prednisone (19) 19
gene expression (18) 18
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (810) 810
French (60) 60
Portuguese (13) 13
German (3) 3
Spanish (3) 3
Polish (2) 2
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Revue de philosophie économique, ISSN 1376-0971, 2018, Volume 19, Issue 1, p. 169
Journal Article
Revue de philosophie économique, ISSN 1376-0971, 2018, Issue 1, pp. 169 - 179
Journal Article
01/2019, ISBN 9783030003616, 358
eBook
2019, Hematologic malignancies (Series), ISBN 9783030003616
eBook
Hématologie, ISSN 1264-7527, 01/2017, Volume 23, Issue S1, pp. 4 - 4
Journal Article
La Presse Médicale, ISSN 0755-4982, 07/2019, Volume 48, Issue 7-8, pp. 850 - 858
Le lymphome folliculaire, 2 lymphome le plus fréquent, est une pathologie caractérisée par une croissance lente et qui est souvent considéré comme incurable... 
Journal Article
Hématologie, ISSN 1264-7527, 03/2015, Volume 21, Issue S2, pp. 3 - 3
Journal Article
La Presse Médicale, ISSN 0755-4982, 07/2019, Volume 48, Issue 7-8, pp. 859 - 870
Les lymphomes à petites cellules non folliculaires regroupent plusieurs entités dont la description clinique et pathologique s’est affinée dans les... 
Journal Article
Hematologie, ISSN 1264-7527, 01/2017, Volume 23, p. 4
Journal Article
Hematologie, ISSN 1264-7527, 03/2015, Volume 21, p. 3
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1604 - 1604
Abstract Introduction Ibrutinib, a first-in-class, oral, covalent inhibitor of Bruton's tyrosine kinase, is approved in several countries as monotherapy for... 
Journal Article
PRESSE MEDICALE, ISSN 0755-4982, 07/2019, Volume 48, Issue 7-8, pp. 850 - 858
Follicular lymphoma, the second most common lymphoma, is characterized by its slow growth and is often considered incurable in advanced stages. Progresses in... 
1ST-LINE TREATMENT | ADVANCED-STAGE | TRANSLOCATION | MEDICINE, GENERAL & INTERNAL | CYCLOPHOSPHAMIDE | RITUXIMAB | VINCRISTINE | RISK | OPEN-LABEL | PHASE-3 | GENOME-WIDE ASSOCIATION
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 09/2019, Volume 104, Issue 10, pp. E487 - E488
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4427 - 4427
Abstract Introduction Ibrutinib, a first-in-class, oral, covalent inhibitor of Bruton's tyrosine kinase, is approved in many countries for treatment-naïve (TN)... 
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 22, pp. 2185 - 2186
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4191 - 4191
Abstract Introduction: Epigenetic modulation of histones plays a critical role in lymphomagenesis. The histone-methyl transferase EZH2 is the catalytic subunit... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5924 - 5924
Abstract INTRODUCTION Idelalisib (IDELA), the first-in-class PI3K-delta inhibitor, is indicated in Europe in combination with rituximab (R) or ofatumumab for... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 778 - 778
Abstract Introduction: Follicular lymphoma (FL) is graded as 1, 2, 3A and 3B based on the number of centroblast cells. Although FL grade 3A is considered as a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5345 - 5345
Abstract Introduction: Tirabrutinib (TIRA; GS/ONO-4059) is a selective Bruton's tyrosine kinase (BTK) inhibitor. Idelalisib (IDELA), a first-in-class... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.